Patients with Coronary Artery Disease or At High Cardiovascular Risk: Measuring Compliance with Treatment for Obstructive Sleep Apnea Syndrome

Inclusion Criteria

• •Target population: with coronary artery disease or at very high risk of coronary artery disease:
• •Patients with coronary artery disease with or without co-morbidities (smoking, diabetes, hypertension, dyslipidaemia, renal insufficiency, overweight, emerging factors including anxiety-depression, shift workers, etc.).
• •Hypertensive patients at high cardiovascular risk (target organ damage such as LVH or albuminuria)
• •Diabetic patients at high cardiovascular risk
• •Type of heart disease: ischaemic heart disease without clinically significant heart failure (NYHA II, III, IV) For the experimental group (MAD): patients with moderate or severe OSA with intolerance or refusal of CPAP and managed by MAD.
• •For the control group (CPAP): patients with moderate or severe OSA treated with CPAP.